首页 | 本学科首页   官方微博 | 高级检索  
检索        


A case of refractory cutaneous polyarteritis nodosa in a patient with hepatitis B carrier status successfully treated with tumor necrosis factor alpha blockade
Authors:Takeshi Zoshima  Masami Matsumura  Yasunori Suzuki  Yasushi Kakuchi  Ichiro Mizushima  Hiroshi Fujii  Kazunori Yamada  Masakazu Yamagishi  Mitsuhiro Kawano
Institution:1. Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan
2. Research Center for Medical Education, Graduate School of Medicine, Kanazawa University, Takara-machi 13-1, Kanazawa, 920-8640, Japan
3. Division of Cardiology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan
Abstract:We describe a patient with refractory cutaneous polyarteritis nodosa (CPAN) with hepatitis B virus (HBV) carrier status who was successfully treated with tumor necrosis factor alpha (TNF-α) blockade, using etanercept, and we review 5 similar cases. We administered etanercept because of the occurrence of repeated flares despite aggressive therapy. C-reactive protein normalization; prednisolone dose-sparing; and absence of any adverse events, including HBV reactivation with nucleotide analogue administration, or renal dysfunction, have been achieved for 8 months. TNF-α blockade should be considered for intractable CPAN.
Keywords:Cutaneous polyarteritis nodosa  Etanercept  Hepatitis B  Tumor necrosis factor alpha blockade
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号